Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders


Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 1, March

Pain and Child: A Translational Hypothesis on the Pathophysiology of a Mild Type-2 Diabetes Model

Volume:11   Issue: 1
Pp: 1-7
S. Loizzo, A. Capasso, A. L. Loizzo, S. Spampinato, G. Campana, A. Di Giannuario, S. Pieretti and A. Loizzo
DOI: 10.2174/187153011794982040
Published on: 01 March, 2012

Cystic Fibrosis and the Innate Immune System: Therapeutic Implications

Volume:11   Issue: 1
Pp: 8-22
Massimo Conese
DOI: 10.2174/187153011794982022
Published on: 01 March, 2012

The Evil Axis of Obesity, Inflammation and Type-2 Diabetes

Volume:11   Issue: 1
Pp: 23-31
Arghya Das and Sangita Mukhopadhyay
DOI: 10.2174/187153011794982086
Published on: 01 March, 2012

Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery

Volume:11   Issue: 1
Pp: 32-53
Nisar Ahmed Khan and Robbert Benner
DOI: 10.2174/187153011794982031
Published on: 01 March, 2012

TRP Channels and Cancer: New Targets for Diagnosis and Chemotherapy

Volume:11   Issue: 1
Pp: 54-67
Giorgio Santoni and Valerio Farfariello
DOI: 10.2174/187153011794982068
Published on: 01 March, 2012

Application of Innate Immune Molecules for a New Class of Drugs: Infection, Inflammation and Beyond

Volume:11   Issue: 1
Pp: 68-75
H. J. Kimura, K. Suzuki, M. A. Landek-Salgado, P. Caturegli, N. Jounai, K. Kobiyama and F. Takeshita
DOI: 10.2174/187153011794982077
Published on: 01 March, 2012

HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy

Volume:11   Issue: 1
Pp: 76-89
Wei-Hua Yan
DOI: 10.2174/187153011794982059
Published on: 01 March, 2012